In yet another collaboration with the NYC Tech Talent Pipeline and Mayor Bill de Blasio’s administration, a New York-based coding academy called the Flatiron School is inviting more folks to its ...

Our Regions National View More in National › Europe View More in Europe › Boston View More in Boston › Boulder/Denver View More in Boulder/Denver › Detroit/Ann Arbor View More in Detroit/Ann Arbor › ...

This week’s New England life sciences news was dominated by area drugmakers. —Healthcare companies accounted for more than 75 percent of the $156.5 million brought in by Massachusetts startup ...

CircleCI, which offers tools for companies seeking to speed up the process of developing their own software, announced today that it has raised $31 million in a Series C fundraising round. The San ...

Palo Alto, CA-based BridgeBio Pharma (NASDAQ: BBIO) has named Eli Wallace as its chief scientific officer in residence for oncology. In this role, Wallace will oversee the company’s current drug ...

Bankrate, the New York-based aggregator and publisher of online content about personal finance, announced yesterday that it acquired the Detroit credit-monitoring company Quizzle. The terms of the ...

Building momentum for a new startup accelerator can take time, and it’s probably too early to pass judgment on The Water Council’s water tech accelerator in Milwaukee, which launched last year. But ...

San Antonio—Richard Grote wants to bring a little bit of the Rocky Mountain High to San Antonio. No, not that high—we’re referring to the buzz that comes from a vibrant innovation ecosystem. Grote, ...

John Heltzel may have delivered the deadpan quote of the week at the 2013 Esri Users Conference in San Diego, when he told a group of senior business executives, “It is not a good day in emergency ...

The state budget being hashed out in Olympia is spreading angst far and wide, and you can bet Washington state’s biotech community will feel it this time. The Life Sciences Discovery Fund, the program ...

It’s notoriously tough to develop just about anything that helps patients with glioblastoma, an aggressive brain cancer, live longer. It’s just as hard to develop a vaccine that provides any sort of ...

Stem cell transplants are risky business, and although their use to treat cancer and other blood-borne diseases has increased in recent years, they remain dangerous and in many cases a last resort.